Candel Therapeutics Inc. (NASDAQ: CADL)
$8.7400
-0.0100 ( +1.42% ) 18.9K
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$8.7400
Previous close
$8.7500
Volume
18.9K
Market cap
$389.16M
Day range
$8.5350 - $9.1590
52 week range
$1.1000 - $14.6000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Nov 21, 2024 |
| 8-k | 8K-related | 13 | Nov 14, 2024 |
| 10-q | Quarterly Reports | 76 | Nov 14, 2024 |
| 4 | Insider transactions | 1 | Nov 08, 2024 |
| 4 | Insider transactions | 1 | Nov 01, 2024 |
| 4 | Insider transactions | 1 | Oct 28, 2024 |
| 8-k | 8K-related | 13 | Oct 28, 2024 |
| 4 | Insider transactions | 1 | Oct 15, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 8-k | 8K-related | 13 | Aug 13, 2024 |